Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy
E Muchtar, LA Blauwet, MA Gertz - Circulation research, 2017 - Am Heart Assoc
Restrictive cardiomyopathy (RCM) is characterized by nondilated left or right ventricle with
diastolic dysfunction. The restrictive cardiomyopathies are a heterogenous group of …
diastolic dysfunction. The restrictive cardiomyopathies are a heterogenous group of …
[HTML][HTML] Restrictive cardiomyopathy: from genetics and clinical overview to animal modeling
M Chintanaphol, BO Orgil, NR Alberson… - Reviews in …, 2022 - imrpress.com
Restrictive cardiomyopathy (RCM), a potentially devastating heart muscle disorder, is
characterized by diastolic dysfunction due to abnormal muscle relaxation and myocardial …
characterized by diastolic dysfunction due to abnormal muscle relaxation and myocardial …
Thirty-day readmissions after left ventricular assist device implantation in the United States: insights from the nationwide readmissions database
Background: Early readmissions contribute significantly to heart failure–related morbidity
and negatively affect quality of life. Data on left ventricular assist device (LVAD)–related 30 …
and negatively affect quality of life. Data on left ventricular assist device (LVAD)–related 30 …
Sex-specific outcome disparities in patients receiving continuous-flow left ventricular assist devices: a systematic review and meta-analysis
V Blumer, R Mendirichaga, GA Hernandez… - ASAIO …, 2018 - journals.lww.com
Continuous-flow left ventricular assist devices (CF-LVADs) decrease mortality and improve
quality of life in patients with advanced heart failure (HF). Their widespread utilization has …
quality of life in patients with advanced heart failure (HF). Their widespread utilization has …
[HTML][HTML] Management of Myocardial Infarction and the Role of Cardiothoracic Surgery
Myocardial infarction (MI) is a leading cause of mortality globally and is predominantly
attributed to coronary artery disease (CAD). MI is categorized as ST-elevation MI (STEMI) or …
attributed to coronary artery disease (CAD). MI is categorized as ST-elevation MI (STEMI) or …
A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition
A Gupta, B Houston - Heart failure reviews, 2017 - Springer
The function of the heart is defined by its ability to deliver adequate cardiac output to meet
the requirements of the body both at rest and with exertion. To fill this role, the heart …
the requirements of the body both at rest and with exertion. To fill this role, the heart …
[HTML][HTML] Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients
C Logan, I Yumul, J Cepeda, V Pretorius… - American Journal of …, 2021 - Elsevier
Outcomes following hepatitis C virus (HCV)-viremic heart transplantation into HCV-negative
recipients with HCV treatment are good. We assessed cost-effectiveness between cohorts of …
recipients with HCV treatment are good. We assessed cost-effectiveness between cohorts of …
Chronic heart failure treatment with the left ventricular assist device
T Capriotti, M Micari - Home healthcare now, 2019 - journals.lww.com
The prevalence of chronic heart failure is increasing in the United States due to the increase
in the number of older adults and because many people are surviving acute cardiac events …
in the number of older adults and because many people are surviving acute cardiac events …
[PDF][PDF] Mechanical Circulatory Support in Cardiogenic Shock: A Narrative Review
D Shah, J Sen - Cureus, 2024 - cureus.com
Cardiogenic shock (CS) remains a critical condition with high mortality rates, often arising
from acute myocardial infarction and advanced heart failure. Despite advancements in …
from acute myocardial infarction and advanced heart failure. Despite advancements in …
Low immunogenic endothelial cells endothelialize the Left Ventricular Assist Device
C Figueiredo, D Eicke, Y Yuzefovych, M Avsar… - Scientific Reports, 2019 - nature.com
Low haemocompatibility of left ventricular assist devices (LVAD) surfaces necessitates
anticoagulative therapy. Endothelial cell (EC) seeding can support haemocompatibility …
anticoagulative therapy. Endothelial cell (EC) seeding can support haemocompatibility …